Showing 19,841 - 19,860 results of 19,995 for search '(((( 50 we decrease ) OR ( 50 ((a decrease) OR (mean decrease)) ))) OR ( a step decrease ))', query time: 0.86s Refine Results
  1. 19841

    Efficiency in finding the nest of homing agents. by Florent Le Möel (8407926)

    Published 2020
    “…<b>A-C.</b> Example paths (120 steps) of 10 individual agents for each condition. …”
  2. 19842

    2021 ASHA Research Symposium: Michael McKee by Michael McKee (13870878)

    Published 2022
    “…</p> <p><strong>Purpose:</strong> Nearly 20% of U.S. Americans report a hearing loss, yet our current health care system is poorly designed and equipped to effectively care for these individuals. …”
  3. 19843

    Table_1_Exposure to Mycotoxin-Mixtures via Breast Milk: An Ultra-Sensitive LC-MS/MS Biomonitoring Approach.docx by Dominik Braun (6033560)

    Published 2020
    “…Analytical methods mostly focused on single exposures in the past, thus neglecting co-occurrences and mixture effects. Here, we present a highly sensitive multi-biomarker approach by a sophisticated combination of steps during sample preparation including a Quick, Easy, Cheap, Effective, Rugged and Safe (QuEChERS) extraction followed by a solid phase extraction (SPE) cleanup and utilizing stable isotopes for compensating challenging matrix effects. …”
  4. 19844

    Table_3_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.csv by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  5. 19845

    Table_2_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.csv by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  6. 19846

    Image_1_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.jpeg by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  7. 19847

    Table_1_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.csv by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  8. 19848

    Image_2_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.jpeg by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  9. 19849

    Table_5_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.csv by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  10. 19850

    Table_6_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.csv by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  11. 19851

    Table_4_Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.xlsx by Orsolya Tünde Kovács (5055590)

    Published 2022
    “…Interestingly, the differences between cells of healthy donors and RA/PsA patients are most pronounced after the final steps of differentiation to osteoclasts. …”
  12. 19852

    Size and temporal dynamics of EPS digestion. by Sammy Pontrelli (10744534)

    Published 2025
    “…<p><b>A)</b> Number of ions in each enzyme digest falling in the decreased, bell-shaped, or increased categories. …”
  13. 19853

    Data Sheet 1_The response regulator CrsR positively regulates ansamitocin P-3 biosynthesis in Actinosynnema pretiosum.docx by Peipei Zhang (1360440)

    Published 2025
    “…<p>Ansamitocin P-3 (AP-3), a maytansinoid antibiotic produced by Actinosynnema pretiosum, exhibits potent anticancer activity. …”
  14. 19854

    Dibenzo[<i>hi</i>,<i>st</i>]ovalene as Highly Luminescent Nanographene: Efficient Synthesis via Photochemical Cyclodehydroiodination, Optoelectronic Properties, and Single-Molecule... by Qiang Chen (114038)

    Published 2019
    “…Remarkably, the intersystem crossing rate into the triplet state decreased by more than an order of magnitude at low temperature, demonstrating that temperature can be a crucial parameter to boost single photon emission of an aromatic hydrocarbon.…”
  15. 19855

    Dibenzo[<i>hi</i>,<i>st</i>]ovalene as Highly Luminescent Nanographene: Efficient Synthesis via Photochemical Cyclodehydroiodination, Optoelectronic Properties, and Single-Molecule... by Qiang Chen (114038)

    Published 2019
    “…Remarkably, the intersystem crossing rate into the triplet state decreased by more than an order of magnitude at low temperature, demonstrating that temperature can be a crucial parameter to boost single photon emission of an aromatic hydrocarbon.…”
  16. 19856

    Mature microRNA-binding protein QKI promotes microRNA-mediated gene silencing by Kyung-Won Min (15094395)

    Published 2024
    “…We also revealed that QKI overexpression suppresses cMYC expression at post-transcriptional level, and decreases proliferation and migration of HeLa cells, demonstrating that QKI is a tumour suppressor gene by in part augmenting let-7b activity. …”
  17. 19857

    DataSheet_2_Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology.pdf by Sandrine Schmutz (2922075)

    Published 2024
    “…We conclude that spectral flow cytometry is a highly valuable tool for high-end immunophenotyping, and that fine-tuning of major experimental steps is key for taking advantage of its full capacity.…”
  18. 19858

    DataSheet_5_Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology.pdf by Sandrine Schmutz (2922075)

    Published 2024
    “…We conclude that spectral flow cytometry is a highly valuable tool for high-end immunophenotyping, and that fine-tuning of major experimental steps is key for taking advantage of its full capacity.…”
  19. 19859

    DataSheet_3_Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology.pdf by Sandrine Schmutz (2922075)

    Published 2024
    “…We conclude that spectral flow cytometry is a highly valuable tool for high-end immunophenotyping, and that fine-tuning of major experimental steps is key for taking advantage of its full capacity.…”
  20. 19860

    DataSheet_4_Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology.pdf by Sandrine Schmutz (2922075)

    Published 2024
    “…We conclude that spectral flow cytometry is a highly valuable tool for high-end immunophenotyping, and that fine-tuning of major experimental steps is key for taking advantage of its full capacity.…”